US Stocks
/
Pliant Therapeutics, Inc. Share Price

Pliant Therapeutics, Inc. Share Price

NASDAQ: PLRX | Micro Cap
$1.02
+$0.02 (1.49%) Last updated on 09 Oct, 2026 | 21:59 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Pliant Therapeutics, Inc. Stock Performance

Open
$1.02
Prev. Close
$1.00
Circuit Range
N/A
Day Range
$1.01 - $1.02
Year Range
$0.97 - $1.94
Volume
4,248
Average Traded
$1.02

Pliant Therapeutics, Inc. Share Price Today

As of 9 October 2026, Pliant Therapeutics, Inc.'s share price is $1.02. The stock opened at $1.02, compared to its previous close of $1.00. During today's trading session, Pliant Therapeutics, Inc.'s share price traded between $1.01 and $1.02, with an average price of $1.02. Over the past 52 weeks, the stock has recorded a high of $1.94 and a low of $0.97. In terms of performance, Pliant Therapeutics, Inc.'s share price has declined by 16.73% over the last six months and is down 39.47% on a year-on-year basis.

Pliant Therapeutics, Inc. Share Price Chart

$1.01$1.02
L
Show Current Price
H

Pliant Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$62.59M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.49
Revenue (TTM)
$0.00
Return On Equity (TTM)
-62.81%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
14.94%

Pliant Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$26.30-$23.58-$20.04-$22.37
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A10.34%15.01%-11.63%

Pliant Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$9.69$1.58$0.00$0.00
Net Profit-$123.32-$161.34-$210.30-$149.34
Net Profit Margin-1272.65%-10211.39%N/AN/A
Income ChangeN/A-30.83%-30.35%28.99%

About Pliant Therapeutics, Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Pliant Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.09
$1.02
-5.56%
Sep 2026
$1.10
$1.08
-6.49%
Aug 2026
$1.05
$1.16
+10.53%
Jul 2026
$1.15
$1.04
-8.33%
Jun 2026
$1.25
$1.14
-10.24%
May 2026
$1.22
$1.27
+3.67%
Apr 2026
$1.29
$1.23
-3.92%
Mar 2026
$1.26
$1.27
-1.16%
Feb 2026
$1.22
$1.29
+5.74%
Jan 2026
$1.23
$1.22
+0.83%
Dec 2025
$1.58
$1.21
-24.84%
Nov 2025
$1.72
$1.61
-4.45%

PLRX Share Price FAQs

What is Pliant Therapeutics, Inc. share price today?

chevron-up
Pliant Therapeutics, Inc. share price today is $1.02 as on October 9, 2026 at 9:59 pm IST.

What is the 52 week high and 52 week low of Pliant Therapeutics, Inc. stock?

chevron-up
The 52 week high of Pliant Therapeutics, Inc. stock is $1.94, while the 52 week low is $0.97 as of 9 Oct '26.

What is PLRX's market capitalisation today?

chevron-up
PLRX market capitalisation is $62.59M as of October 9, 2026, at 10:15 pm IST.

What is PLRX's net income for the last quarter?

chevron-up
PLRX's net income for the last quarter is -22.37B USD.

What is the 5 year returns of PLRX?

chevron-up
The 5 year returns of PLRX is -93.60% as on 9 Oct '26.

What is the high & low stock price of PLRX today?

chevron-up
PLRX stock price hit a high of $1.02 and low of $1.01 as of 9 Oct '26.

Can I buy PLRX shares in India?

chevron-up
Yes. You can buy PLRX in India by opening an international trading account.